Introduction on chromosome 6 (Mohlke et al., 1996; Nichols et al., 1994). von Willebrand factor (VWF) is a multimeric plasma gly-
We now report the identification of Mvwf as a gaincoprotein that plays an essential role in hemostasis.
of-function regulatory mutation in the gene encoding an In plasma, VWF stabilizes coagulation factor VIII and N-acetylgalactosaminyltransferase, GALGT2. The RIIIS/J mediates the adhesion and aggregation of platelets to Mvwf allele switches Galgt2 gene expression from prethe subendothelium at sites of vascular injury, especially dominantly gastrointestinal epithelial cell-specific to a under conditions of high shear (Savage et al., 1996) . pattern largely restricted to the vascular endothelial cell, VWF is synthesized exclusively in megakaryocytes and the latter coincident with the site of plasma VWF syntheendothelial cells and is often used as a specific marker sis. The resulting aberrant posttranslational modificafor the endothelial cell lineage. Endothelial cell-derived tion of VWF by GALGT2 leads to dramatically increased VWF can be secreted by a constitutive pathway or can clearance from plasma, accounting for the low VWF induce the formation of Weibel-Palade bodies for reguphenotype. lated secretion (Wagner et al., 1991) . Extensive posttranslational modification of VWF includes glycosylation, sulfation, multimerization, and propeptide cleavage Results
(Nichols and Ginsburg, 1997).
Qualitative or quantitative abnormalities of VWF funcTo identify the gene responsible for low plasma VWF tion result in von Willebrand disease (VWD), the most level in RIIIS/J mice, candidate transcripts previously common inherited bleeding disorder of humans, with mapped to the 0.3 cM, ‫003ف‬ kb Mvwf region on mouse prevalence estimated at up to 1% of the population chromosome 11 (Mohlke et al., 1998) were surveyed for ( Rodeghiero et al., 1987) . Seventy percent of VWD is mutations. Of the seventeen putative expressed seclassified as type 1, characterized by quantitative reducquences in this region, complete coding sequence was tion of plasma VWF to 20%-50% of the normal level.
available for an ATP synthase (Atp6n1), gastric inhibitory peptide (Gip), and a known but previously unmapped gene encoding an N-acetylgalactosaminyltransferase
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that we termed Galgt2. The enzyme activity associated predicted size was observed in the small intestine sample from the CASA/Rk mouse but not in any tissues from the RIIIS/J mouse. Levels of Galgt2 mRNA detected in small intestine from two additional wild-type strains (C57BL/6J and 129/Sv) were similar to CASA/Rk, and the level from an (RIIIS/J ϫ CASA/Rk) F 1 mouse appeared to be decreased by approximately 50% (data not shown). These results indicate that the gastrointestinal-specific expression of Galgt2 observed in most wild-type mouse strains has been lost in RIIIS/J. 11-week-old Galgt2-deficient mice (produced from an eight-generation backcross to C57BL/6J). The mean with the Galgt2 gene generates the T lymphocyte-VWF level of Galgt2-deficient mice (0.10 Ϯ 0.05 units/ specific CT oligosaccharide differentiation antigen, and ml) was not significantly different from the mean for 13 the human homolog of Galgt2 is thought to generate control C57BL/6J mice (0.13 Ϯ 0.04 units/ml, P Ͼ 0.24). the structure recognized as the human blood group Sd a These results indicate that Galgt2 gene expression is oligosaccharide (Smith and Lowe, 1994 , 1985) . The DBA lectin recognizes candidate loci, RNA PCR products spanning polymorphic nucleotides were amplified from total RNA preterminal nonreducing N-acetylgalactosamine (GalNAc) residues. The Dlb1 polymorphism is characterized by pared from liver (Atp6n1) or small intestine (Gip and Galgt2) of RIIIS/J, CASA/Rk, and (RIIIS/J ϫ CASA/Rk)F 1 DBA binding primarily restricted to the intestinal epithelium of C57BL/6 and most other mouse strains, in conmice (abbreviated F 1 ). Atp6n1 and Gip PCR products from F 1 RNA showed equivalent expression from both trast to the pattern of DBA binding to the vascular endothelium and absence from the epithelium observed in alleles (Figure 1 and data not shown) . In contrast, Galgt2 mRNA amplification from F 1 samples only detected a the RIII strain (an ancestral strain of RIIIS/J). Though the nature of the locus that determined expression of DBAsignal from the CASA/Rk allele (Figure 1) . These results suggested that the CASA/Rk allele of Galgt2 is preferenpositive tissues was not known, this lectin's specificity for GalNAc and GalNAc-substituted glycans suggested tially expressed in F 1 mice.
Normal Plasma VWF Levels
To further characterize the apparently altered Galgt2 that the Dlb1 polymorphism was determined by tissuespecific expression of a GalNAc transferase (Ponder et mRNA expression pattern in RIIIS/J mice, a Galgt2 RNase protection assay was performed on small inal., 1985a).
To examine the potential relationship between Dlb1 testine, kidney, liver, lung, spleen, and brain of adult RIIIS/J and CASA/Rk mice. A protected fragment of the and Galgt2, we used immunofluorescence to examine 
GALGT2-Mediated Transfer of GalNAc onto VWF
To determine if VWF can display the proper precursor Additional tissues were analyzed for DBA-binding in all of the above strains. In RIIIS/J and F 1 mice, the DBA sugar structure substrate for modification by GALGT2, recombinant VWF was synthesized in the presence or signal was present in major blood vessels of the spleen and kidney and was coincident with the location of VWF, absence of GALGT2 and subsequently assayed for the GalNAc modification. Control CHO cells and CHO cells as observed in the intestinal microvasculature. No DBA signal was detected in these tissues in the other mouse stably expressing Galgt2 were transiently transfected with an expression vector containing the full-length hustrains, aside from staining in a subset of kidney tubules in C57BL/6J mice (data not shown).
man VWF cDNA. Conditioned media prepared from both cell types contained similar levels of VWF antigen. Media Analysis of Galgt2 mRNA expression by in situ hybridization detected a strong signal in the colon epithelium were also analyzed by a modified sandwich ELISA for the presence of DBA-detectable GalNAc on VWF. A strong of C57BL/6J, with no specific signal evident in the spleen. In contrast, in the RIIIS/J mouse, Galgt2 expressignal was observed for VWF synthesized in Galgt2-expressing cells (Ͼ12 ϫ background). In contrast, no sion was clearly evident in the splenic vascular endothelium but was undetectable in the colon (Figure 3 ). These DBA-specific signal was detected for VWF synthesized in control Galgt2-negative cells. These results indicate data demonstrate that the Dlb1 polymorphism detected that GALGT2 can modify the human VWF protein to levels, we measured the clearance rate of exogenously administered, epitope-tagged, recombinant human VWF contain the structure recognized by the DBA lectin and that this reactivity is not detectable in the absence of with or without modification by GALGT2. Concentrated conditioned media containing these recombinant forms Galgt2.
To determine if a significant fraction of RIIIS/J mouse of VWF were injected into the tail veins of C57BL/6J mice. Blood samples were subsequently collected at plasma VWF contains the GALGT2-dependent structure recognized by the DBA lectin, plasma samples were times up to 45 min postinjection, and the relative amount of epitope-tagged VWF was determined. VWF modified tested in the same DBA-VWF ELISA. No DBA-detectable GalNAc signal was observed in RIIIS/J, CASA/Rk, F 1 , by GALGT2 was cleared rapidly from plasma, relative to unmodified VWF ( Figure 5 ). The half-life (t 1⁄2 ) of modified C57BL/6J, or Galgt2-deficient mice, suggesting that few or no terminal GalNAc residues are present on circulat-VWF was ‫52ف‬ min, while the t 1⁄2 of unmodified VWF was ‫003ف‬ min. The latter value is comparable to the ‫4ف‬ hr ing murine plasma VWF. These results are consistent with the hypothesis that GALGT2-modified VWF is either t 1⁄2 of recombinant human VWF in the rat (Stoddart et al., 1996) 
1985). ABO blood group is determined by polymorphism in the glycosyltransferases
The Galgt2 cDNA used encompasses the entire coding region of the RNA in situ hybridization was performed as described (Smith et al., gene (Smith and Lowe, 1994) but lacks most untranslated sequence. 1996) using frozen sections of small intestine, kidney, spleen, and
To facilitate detection of the transgene on an endogenous backcolon from 12-week-old RIIIS/J and C57BL/6J mice. The Galgt2 ground, 23 nucleotides of the 3Ј untranslated region were removed probe consists of nucleotides 45-361 of the Galgt2 sequence (Smith by a PCR technique using the primer 5Ј-GCTCTAGATGTTGCCCGC and Lowe, 1994). Slides were exposed to emulsion for ten days to CGCTAATCTGTTCTTTTTAAGTGGAGCAGTAGAG-3Ј (an underline four weeks.
indicates the nucleotides flanking the deletion). The construct (Figure 6A) consisted of a 2.1 kb HindIII Tie2 promoter fragment followed by a 1.6 kb XhoI Galgt2 cDNA fragment followed by an SV40 intron 
